Skip to content

Drug interactions

Imatinib + Repotrectinib

Severity: Major

Imatinib and Repotrectinib: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Imatinib may increase repotrectinib exposure, potentially worsening dizziness, ataxia, cognitive effects and other adverse reactions.

What this interaction means in plain words

Imatinib and Repotrectinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Imatinib belongs to Oncology; Repotrectinib belongs to Oncology.

Evidence level: Moderate

Why it happens

Imatinib inhibits CYP3A4, the main enzyme metabolizing repotrectinib.

What to do

Avoid the combination where possible. If unavoidable, monitor closely for neurologic toxicity and reduce the repotrectinib dose as labeled.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Imatinib and Repotrectinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Imatinib with Repotrectinib?

MediHelp rates the interaction as major. Imatinib and Repotrectinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Imatinib may increase repotrectinib exposure, potentially worsening dizziness, ataxia, cognitive effects and other adverse reactions.

How serious is the interaction between Imatinib and Repotrectinib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination where possible. If unavoidable, monitor closely for neurologic toxicity and reduce the repotrectinib dose as labeled.

What other medicines interact with Imatinib?

MediHelp also lists interactions of Imatinib with, for example, Lomitapide, Lonafarnib, Amobarbital. The full list is on the Imatinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in